top of page
Thomas Ciriacks
Board Advisor: Business Development & Strategic Communications
With 25+ years of expertise in biotech and sterile injectables, including pain medicine, anesthesia, ambulatory surgery, oncology, CNS, and infectious disease, Thomas has developed leading U.S. research and communication platforms and built strong relationships with top KOLs and industry leaders. Thomas and his team has in-depth knowledge and expertise for actionable strategic BioPharma positioning and business insights, leveraging qualitative SME intelligence and quantitative product landscape analysis and positioning, including regulatory-aligned narratives. Thomas specializes in bridging complex science with strategy to drive high-impact outcomes.

bottom of page